Due to the ongoing uncertainty and impact of COVID-19 on travel, EORTC QLG Autumn meeting will now be held virtually on the 17-18 of September 2020. The Executive Commission will now be working on the set up for this virtual meeting and details will be sent during the summer. This means that the 40th anniversary celebration has also been postponed and instead will be held in 2021. Further details on this will be sent in the future when there is more clarity. We are sorry if this change of plans has caused you any inconvenience.
“Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors”
17 May 2021
“Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial”
14 May 2021